Sweet Syndrome Following SARS-CoV2 Vaccination

被引:17
作者
Baffa, Maria Efenesia [1 ]
Maglie, Roberto [1 ]
Giovannozzi, Neri [2 ]
Montefusco, Francesca [1 ]
Senatore, Stefano [1 ]
Massi, Daniela [2 ]
Antiga, Emiliano [1 ]
机构
[1] Univ Florence, Dermatol Sect, Dept Hlth Sci, I-50125 Florence, Italy
[2] Univ Florence, Sect Pathol Anat, Dept Hlth Sci, I-50139 Florence, Italy
关键词
Sweet's syndrome; mRNA vaccines; neutrophilic dermatoses; adverse event; FEBRILE NEUTROPHILIC DERMATOSIS; MOLECULES;
D O I
10.3390/vaccines9111212
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccines are today considered one of the most effective means against the Sars-CoV-2 pandemic. The BNT162b2 vaccine by Pfizer/BioNTech has been massively administered throughout the globe; since its approval, a wide spectrum of cutaneous reactions has been reported. Here we report the case of a 52-year-old Caucasian male who presented with an acute febrile eruption that arose 72 h after the first dose of the BNT162b2 vaccine. The clinicopathological findings were consistent with Sweet's syndrome. The short latency time suggested a possible role of the vaccine in triggering Sweet's syndrome in this case.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Decreased and Heterogeneous Neutralizing Antibody Responses Against RBD of SARS-CoV-2 Variants After mRNA Vaccination
    Hernandez-Luis, Pablo
    Aguilar, Ruth
    Pelegrin-Perez, Judit
    Ruiz-Olalla, Gemma
    Garcia-Basteiro, Alberto L.
    Tortajada, Marta
    Moncunill, Gemma
    Dobano, Carlota
    Angulo, Ana
    Engel, Pablo
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [32] Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis
    Matteo Castaldo
    Marta Waliszewska-Prosół
    Maria Koutsokera
    Micaela Robotti
    Marcin Straburzyński
    Loukia Apostolakopoulou
    Mariarita Capizzi
    Oneda Çibuku
    Fidel Dominique Festin Ambat
    Ilaria Frattale
    Zukhra Gadzhieva
    Erica Gallo
    Anna Gryglas-Dworak
    Gleni Halili
    Asel Jusupova
    Yana Koperskaya
    Alo-Rainer Leheste
    Maria Laura Manzo
    Andrea Marcinnò
    Antonio Marino
    Petr Mikulenka
    Bee Eng Ong
    Burcu Polat
    Zvonimir Popovic
    Eduardo Rivera-Mancilla
    Adina Maria Roceanu
    Eleonora Rollo
    Marina Romozzi
    Claudia Ruscitto
    Fabrizio Scotto di Clemente
    Sebastian Strauss
    Valentina Taranta
    Maria Terhart
    Iryna Tychenko
    Simone Vigneri
    Blazej Misiak
    Paolo Martelletti
    Alberto Raggi
    The Journal of Headache and Pain, 2022, 23
  • [33] Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis
    Jahn, Michael
    Korth, Johannes
    Dorsch, Oliver
    Anastasiou, Olympia Evdoxia
    Sorge-Haedicke, Burkhard
    Tyczynski, Bartosz
    Gaeckler, Anja
    Witzke, Oliver
    Dittmer, Ulf
    Dolff, Sebastian
    Wilde, Benjamin
    Kribben, Andreas
    VACCINES, 2021, 9 (04)
  • [34] Expression of SARS-CoV-2 spike protein in cerebral Arteries: Implications for hemorrhagic stroke Post-mRNA vaccination
    Ota, Nakao
    Itani, Masahiko
    Aoki, Tomohiro
    Sakurai, Aki
    Fujisawa, Takashi
    Okada, Yasuaki
    Noda, Kosumo
    Arakawa, Yoshiki
    Tokuda, Sadahisa
    Tanikawa, Rokuya
    JOURNAL OF CLINICAL NEUROSCIENCE, 2025, 136
  • [35] An Elderly Patient Developed Ulcerative Colitis after SARS-CoV-2 mRNA Vaccination: A Case Report and Review of the Literature
    Shimada, Takahito
    Takada, Jun
    Baba, Atsushi
    Iwashita, Masahide
    Hayashi, Takao
    Maeda, Teruo
    Shimizu, Masahito
    INTERNAL MEDICINE, 2024, 63 (06) : 809 - 814
  • [36] SARS-CoV-2 vaccines: Lights and shadows
    Angeli, Fabio
    Spanevello, Antonio
    Reboldi, Gianpaolo
    Visca, Dina
    Verdecchia, Paolo
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 88 : 1 - 8
  • [37] Sweet's syndrome after H1N1 influenza vaccination
    Hali, F.
    Sbai, M.
    Benchikhi, H.
    Ouakadi, A.
    Zamiati, S.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2010, 137 (11): : 740 - 741
  • [38] IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein
    Uversky, Vladimir N.
    Redwan, Elrashdy M.
    Makis, William
    Rubio-Casillas, Alberto
    VACCINES, 2023, 11 (05)
  • [39] Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses
    Buckner, Clarisa M.
    Kardava, Lela
    El Merhebi, Omar
    Narpala, Sandeep R.
    Serebryannyy, Leonid
    Lin, Bob C.
    Wang, Wei
    Zhang, Xiaozhen
    Assis, Felipe Lopes de
    Kelly, Sophie E. M.
    Teng, I-Ting
    McCormack, Genevieve E.
    Praiss, Lauren H.
    Seamon, Catherine A.
    Rai, M. Ali
    Kalish, Heather
    Kwong, Peter D.
    Proschan, Michael A.
    McDermott, Adrian B.
    Fauci, Anthony S.
    Chun, Tae-Wook
    Moir, Susan
    CELL, 2022, 185 (23) : 4333 - +
  • [40] Safety, efficacy, and immunogenicity of SARS-CoV-2 mRNA vaccination in children and adult patients with rheumatic diseases: a comprehensive literature review
    Dhanasekaran, Preeti
    Karasu, Biraveena Thirunavuc
    Mak, Anselm
    RHEUMATOLOGY INTERNATIONAL, 2024, 44 (12) : 2757 - 2794